Insights Newsletter May 2025: Emerging Trends for Clinical Leadership

May 14, 2025

This month’s Insights Newsletter covers the latest practice-changing pharmacy updates, emerging trends, and popular natural medicine topics and resources.

Insights Newsletter | May 2025

Read Newsletter

Explain How Meds for Glaucoma Stack Up

Recent guidelines are leading to questions about how meds for open-angle glaucoma compare. Our articles review the various types of eye drops for this condition and their place in therapy. Your team can use these articles to help choose an appropriate medication for open-angle glaucoma, advise on appropriate dosing and administration, and counsel about potential side effects. Readers can also get our updated chart, Drugs for Open-Angle Glaucoma, for a comprehensive comparison of options, approximate cost, and more. Read More

Community Pharmacies: Understand the Role of OTC Continuous Glucose Monitoring

Expanded guideline recommendations will bring up questions about the new OTC continuous glucose monitoring (CGM) devices. Your team can use these articles to help describe how OTC CGMs compare to Rx options. These articles also cover the role of OTC CGMS and which patients should not rely on an OTC option. Your team can also get our resource Continuous Glucose Monitoring for more comparisons and answers to FAQs. Read More

Hospitals: Weigh Pros and Cons of Balanced IV Fluids in the ICU

Continuing IV fluid shortages are highlighting questions about the best fluid choices for resuscitating critically ill patients. Our articles differentiate crystalloid options and show how they compare in a succinct chart. Your team can also use these articles to help recommend an appropriate type of fluid based on a patient’s clinical condition. Readers can learn more about product differences and ways to prevent errors with our chart, IV Fluid Safety. Read More

Natural Medicines: Talk to Patients about Vitamin A and Measles

The recent measles outbreak is stirring up discussions about vitamin A for both prevention and treatment. Providers need to be prepared to discuss this. Our NatMed article explains that vitamin A should be considered in measles treatment, but not prevention. We discuss the available evidence, noting that most studies evaluating vitamin A for prevention have been conducted in countries where kids are at high risk for deficiency. Providers should continue to advise vaccination. Read More

Pharmacy & Prescriber Podcasts

Medication Talk

Listen to this month’s podcast episode, Medications for Opioid Use Disorder, as our expert panel discusses medications for management of opioid use disorder. They’ll review strategies to optimize buprenorphine use and clarify the role of methadone and naltrexone.   

All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.

New! Rumor vs Truth

Your trusted source for facts, where we dissect the evidence behind risky rumors and reveal clinical truths. This new podcast series is designed to help pharmacists, pharmacy technicians, prescribers, and even patients navigate some of the claims they might see about medication therapy. Our latest episode on risks of dyes in medication will be released on May 20th. In the meantime, check out our past episodes here.

New! Clinical Capsules

Listen to our latest episode, Tailoring Contraceptive Use, as TRC Healthcare editor, Sara Klockars, PharmD, BCPS, discusses tailoring contraceptive use in certain populations based on updated US medical eligibility criteria, patient preferences, and medical history.

Upcoming Tradeshows

We have a packed tradeshow schedule this year and would love to meet with you in person! Send us a meeting request if you’ll be attending any of these shows.

Check out where we’ll be in the coming months: